Navigation Links
GenVault to Present at the BIOCOM Investor Conference
Date:10/27/2008

CARLSBAD, Calif., Oct. 27 /PRNewswire/ -- GenVault Corporation, the leader in room temperature biosample management for genomic discovery, medicine and identification, today announced that David Wellis, Ph.D., GenVault's President and CEO will be presenting at the BIOCOM Investor Conference taking place from October 26-28 in La Jolla, CA. During the presentation, Dr. Wellis will provide an overview of the company including recent customer, technical and strategic developments.

The following are specific details of GenVault's presentation at the conference:

BIOCOM Investor Conference

Date: Tuesday, October 28, 2008

Time: 10:00AM

Location: Hyatt Regency La Jolla

Room: Aventine Ballroom, Room B

About GenVault

GenVault is the global leader in providing biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable and reliable alternative to traditional freezers and DNA purification systems, the company's dry-state platform enables the extraction, preservation, recovery, and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for DNA sample management and preservation. For more information visit GenVault at http://www.genvault.com.

EDITORIAL CONTACTS:

David Wellis, CEO

GenVault Corporation

(760) 268-5256


'/>"/>
SOURCE GenVault Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
2. GenVault Corporation Launches GenTegra(TM) DNA
3. GenVault Expands Scientific Advisory Board
4. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
5. Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing
6. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
7. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
8. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
9. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
10. Potentia Pharmaceuticals to Present ASaP Phase I Clinical Trial Data for POT-4 at the American Academy of Ophthalmology Annual Meeting
11. Savients Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013  Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for ... and preliminary efficacy of the medical technology haMPC ... Osteoarthritis (KOA). To date the trial has had ... The Phase I open label clinical research trial ...
(Date:5/17/2013)... Men’s skin is biologically different than women’s ... and has been known to react more aggressively when hormones ... far from puberty, other acne causing factors like P.acnes bacteria ... threatening skin with unsightly acne scars. Adult acne treatment, Probiotic ... on how to reduce and prevent acne scarring. , ...
(Date:5/17/2013)... Brea, CA (PRWEB) May 17, 2013 IAC ... DisperSol Technologies, a start up laboratory needing to set up ... be moving to a larger facility within a year’s time. ... the knowledge that the laboratory is temporary? What is efficient ... 4 Series modular workstations from IAC Industries. The planners at ...
(Date:5/16/2013)... May 16, 2013 Oven Industries, Inc. ... controllers and temperature sensors since 1964. Expertly ... in industrial control system applications. As one ... includes a generic, control loop feedback system, which helps ... used to adjust a systematic process, using a control ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2New PID Temperature Controllers Announced by Oven Industries Inc. 2
... Oct. 6 Environmental,Tectonics Corporation,s (Amex: ETC ... announced the sale of two (2) BARA-MED(R) XD,Monoplace ... ETC is delighted to work with Saint ... The 597-bed institution,is one of the largest health ...
... 6 Caprion Proteomics Inc. announced,today that it has ... of Allergy and Infectious Diseases (NIAID), a part of ... research in the area,of infectious disease biomarkers., Under ... Caprion,will act as one of two NIAID Clinical Proteomics ...
... AALST , Belgium, AHMEDABAD, India and GOTTINGEN, ... associates,Cardiovascular Center Aalst and J.B. Dahm, MD ... Laboratories joint venture, called imaeon., imaeon ... medical images,analysis for clinical research projects, including ...
Cached Biology Technology:Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey 2Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey 3Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey 4Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract 2Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm 2
(Date:5/16/2013)... and athletes choose to wear the color red when ... Psychological Science , a journal of the Association ... do with their testosterone levels. , The new study, ... of Sunderland and colleagues, demonstrated that males who chose ... higher testosterone levels than other males who chose blue. ...
(Date:5/16/2013)... are about 23 million years old give unprecedented ... order, one of the most species-rich groups among ... paleontologist Professor Bettina Reichenbacher from the Division of ... and Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in Munich ... fish fossils which they assign to the group ...
(Date:5/16/2013)... around the world are meeting next week in ... showcase the latest in research findings about the ... understanding the disorders that affect them., "Canada is ... will showcase the best of neuroscience research done ... President of the Canadian Association for Neuroscience. He ...
Breaking Biology News(10 mins):High-testosterone competitors more likely to choose red 2Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 37th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2
... Netherlands: Transferring just one embryo at a time to ... diagnosis (PGD) and freezing at the blastocyst stage has ... that were as good as those for blastocysts that ... freezing. Their results mean that it will be possible ...
... discovered gene expression differences that could lead to better ... arthritis (JIA). Eventually such findings could enable doctors to ... more severe arthritis, while those likely to have milder ... a greater risk of side effects. The researchers were ...
... Dallas, TX (June 29, 2009) -- A team of experts ... the South African bilateral amputee track athlete, have just published ... Some of their previously confidential findings were presented to ... in May of 2008. Other findings are now being ...
Cached Biology News:Single thawed embryo transfer after PGD does not affect pregnancy rates 2Single thawed embryo transfer after PGD does not affect pregnancy rates 3Gene expression findings a step toward better classification and treatment of juvenile arthritis 2Gene expression findings a step toward better classification and treatment of juvenile arthritis 3Oscar Pistorius: Previously confidential study results released on amputee sprinter 2
1M stock solution (238mg/ml)...
...
Request Info...
... Clone/PAD: ZMD.330. Immunogen: Synthetic peptide ... of rat and mouse protein kinase C ... the rat and mouse PKCzeta protein. ... does not cross-react with PKCiota/lambda. Reactivity: ...
Biology Products: